SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.510
+0.020 (0.57%)
Jul 14, 2025, 4:00 PM - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $234.54 million as of July 14, 2025. Its market cap has decreased by -19.92% in one year.
Market Cap
234.54M
Enterprise Value
191.53M
1-Year Change
-19.92%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $234.54M, a decrease of -79.06%. That is a compound annual growth rate of -32.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 233.21M | 14.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |